Advances in Electric and Magnetic Fields Induced Drug Delivery
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmaceutical Technology, Manufacturing and Devices".
Deadline for manuscript submissions: closed (31 August 2022) | Viewed by 2647
Special Issue Editors
Interests: pulsed electric fields; electroporation; blood brain barrier; drug delivery; MRI; brain tumors
Special Issue Information
Dear Colleagues,
In recent years, the use of external electric and magnetic fields to enhance drug delivery has grown dramatically. Electric fields are being used to cross physical barriers such as vessels or cell membranes either by permeabilization (for example electroporation), electroendocytosis, iontophoresis, or by affecting the para-cellular pathway. Additionally, drug delivery systems such as electroresponsive systems facilitate the delivery of charged or magnetic nanoparticles and conductive polymer-based systems (hydrogel film or nanoparticles). Those systems enable a controlled and localized release of drugs to the desired tissue, limiting systemic side effects. Magnetic fields are being used in combination with magnetic nanoparticles to trigger drug release or to increase drug accumulation in a specific target.
The aim of this Special Issue is to highlight electric and magnetic field-based drug delivery mechanisms.
Authors are invited to submit their original research or review articles within this subject area. Preclinical (in vitro and in vivo) and clinical research as well as theoretical and technical papers are invited.
Dr. Sharabi Shirley
Dr. Itzik Cooper
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Electric and magnetic fields
- Electroporation
- Iontophoresis
- Electro-responsive systems
- Nanoparticles
- Electroendocytosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
